| NCT ID | NCT06801535 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Microstomia |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-02-21 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-02-21 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will investigate the effectiveness of a 3D-printed mouth splint designed to increase dimensions of oral aperture and reduce disability associated with mouth contractures. The validated Mouth Impairment and Disability Assessment (MIDA) survey will be used to objectively measure patient progress in functionality and quality of life.
Eligibility Criteria
Inclusion Criteria: * Patients 2 years to 99 years of age with documented microstomia following burn injuries. * Ability to comply with prescribed home exercises and follow-up visits. Exclusion Criteria: * Cognitive or physical inability to perform the prescribed exercises. * Inability of a caretaker to be able to deliver therapy daily. * Concomitant conditions that may significantly affect oral aperture (e.g., temporomandibular joint (TMJ) disorders).
Contact & Investigator
Christopher Runyan, MD, PhD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT06801535 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 99 Years, studying Microstomia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06801535 currently recruiting?
Yes, NCT06801535 is actively recruiting participants. Contact the research team at csuggs@wakehealth.edu for enrollment information.
Where is the NCT06801535 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT06801535 clinical trial?
NCT06801535 is sponsored by Wake Forest University Health Sciences. The principal investigator is Christopher Runyan, MD, PhD at Wake Forest University Health Sciences. The trial plans to enroll 10 participants.